Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 252.19$. Average daily volumn in 3 months 1.16M. Market cap 71.53B

Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 250.92$. Total volume : 1.56M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price

Previous Close242.54
Day Range243.23-251.26
Bid241.27 x 800
Ask250.75 x 800
Average Volume1.16M
Market Cap71.53B
52 Week Range229.40-277.29
Trailing P/E39.51
Foward P/E20.48
Dividend (Yield %)1.39%
Ex-Dividend Date2022-06-08

Financial Details

According to Becton, Dickinson and Company's financial reports the company's revenue in 2021 were 20.25B an increase( +17.65%) over the years 2020 revenue that were of 17.12B. In 2021 the company's total earnings were 2.09B while total earnings in 2020 were 874M( +128.83%).

Loading ...


Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and ... extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
Total Assets:
Total Cash:

News about "Becton, Dickinson and Company"


Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Nordea Investment Management AB

Source from : Defense World - 14 hours ago

Nordea Investment Management AB cut its stake in shares of Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 3.2% in the 1st quarter, Holdings reports. The firm owned 37,186 shares ...See details»


Diversified Trust Co Trims Stake in Becton, Dickinson and Company (NYSE:BDX)

Source from : Defense World - 19 hours ago

Diversified Trust Co cut its stake in Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 19.9% in the 1st quarter, Holdings Channel reports. The fund owned 1,212 shares of the medical ...See details»


Treat Becton, Dickinson and Company With Care

Source from : - 1 days ago

Becton, Dickinson (BDX) is a medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BDX's fundamental rating was just raised by a sell-side firm to ...See details»


Becton, Dickinson and Co voluntarily recalls some intraosseous products

Source from : Seeking Alpha - 3 days ago

Becton, Dickinson and Company (NYSE:BDX) on Wednesday said it was voluntarily recalling some of its intraosseous products due to some issues. The products being recalled are certain lots of the BD ...See details»


Carnegie Capital Asset Management LLC Has $1.59 Million Position in Becton, Dickinson and Company (NYSE:BDX)

Source from : ETF Daily News - 2 days ago

Carnegie Capital Asset Management LLC raised its stake in Becton, Dickinson and Company (NYSE:BDX – Get Rating) by 9.9% during the 1st quarter, according to the company in its most recent disclosure ...See details»

Analyst Ratings for Becton, Dickinson

Source from : Business Insider - 1 days ago

These 6 analysts have an average price target of $280.83 versus the current price of Becton, Dickinson at $247.86, implying upside. Below is a summary of how these 6 analysts rate ...See details»

Becton, Dickinson and Co - Stock News

Source from : Morningstar%2c Inc. - 18 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


Becton, Dickinson upgraded at Wells Fargo citing defensive qualities

Source from : Seeking Alpha - 1 days ago

The shares of Becton, Dickinson (BDX) are trading higher in the pre-market Friday on low volume after Wells Fargo upgraded the health equipment maker to Overweight from ...See details»

Becton Dickinson buys Durham technology company for $1.5B

Source from : The Business Journals - 19 days ago

A multinational company with revenue topping $20 billion is acquiring a Durham-based firm focused on automation solutions for the pharmacy industry. Becton, Dickinson and Co. (NYSE: BDX), a ...See details»

Becton, Dickinson And Co. To Buy Parata Systems In $1.525 Bln All-cash Deal

Source from : Business Insider - 19 days ago

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Monday a definitive agreement for BD to acquire Parata Systems, an innovative provider of pharmacy automation ...See details»


Wells Fargo Upgrades 'Excellent' Defensive Name Becton, Dickinson and Company

Source from : - 1 days ago

Shares of Becton, Dickinson and Company (NYSE: BDX) were upgraded to Overweight from Equal Weight by Wells Fargo analyst Larry Biegelsen on Friday. Biegelsen has ...See details»

Becton Dickinson to buy pharmacy automation company for $1.5B

Source from : Becker's Hospital Review - 19 days ago

Medical technology company Becton, Dickinson and Co. plans to shell out more than $1.5 billion in cash for Parata Systems, an organization with a $600 million stake in the pharmacy automation market.See details»

Becton Dickinson to acquire Parata Systems for over $1 billion

Source from : Reuters - 19 days ago

June 6 (Reuters) - Medical device maker Becton Dickinson and Co (BDX.N) said on Monday it would acquire Parata Systems in a $1.52 billion all-cash deal, as it expands into the pharmacy automation ...See details»


Analyzing Becton, Dickinson's Short Interest

Source from : Benzinga on - 15 days ago

Becton, Dickinson's (NYSE:BDX) short percent of float has risen 11.94% since its last report. The company recently reported that it has 4.25 million shares sold short, which is 1.5% of all regular ...See details»